TheracosBio is a pharmaceutical company located in Framingham, Massachusetts. TheracosBio discovers, develops and commercializes medicines for important diseases. TheracosBio believes that affordable medications for prevalent conditions may lead to more rapid advances in public health.
TheracosBio has gained FDA approval of its proprietary medicine Brenzavvy™ (bexagliflozin). Press release: https://bit.ly/3HtSZ6y
Company Details
- Employees
- 10
- Founded
- -
- Address
- 945 Concord St, Framingham,massachusetts 01701,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.theracosbio.com/
- HQ
- Framingham, Massachusetts
Theracosbio Questions
Theracosbio's website is http://www.theracosbio.com/
Theracosbio's LinkedIn profile is https://www.linkedin.com/company/theracosbio
Theracosbio has
10 employees.
View email and phone details for 10
employees at Theracosbio.
Theracosbio's industry is
Pharmaceutical Manufacturing
Theracosbio's top competitors are
Pharmaphixx,
Pfizer,
Vera Therapeutics, Inc.,
Bamco Africa,
Equillium, Inc.,
Sernova,
Eledon Pharmaceuticals, Inc.,
Tiximed,
Faraday Pharmaceuticals, Inc.,
Mark Cuban Cost Plus Drug Company, Pbc.
Theracosbio's categories are Pharmaceutical Manufacturing
Theracosbio's founding year is 2000
